Akira A. Shishido

Akira A. Shishido

Auto-generated profile, based on publicly available information

Akira A. Shishido

Division of Infectious Disease, Department of Medicine, Westchester Medical Center at New York Medical College, Valhalla; and

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAkira A. Shishido
Akira A. Shishido
MNMyint Noe
Myint Noe
KSKapil Saharia
Kapil Saharia
PLPaul Luethy
Paul Luethy
Background: Metagenomic next-generation sequencing of microbial cell-free DNA (mcfDNA) allows for non-invasive pathogen detection from plasma. However, there is little data describing the optimal role for this assay in real-world clinical decision making. Methods: We performed a single-center retrospective cohort study of adult patients for whom a mcfDNA (Karius©) test was sent between May 2019 and February 2021. Clinical impact was arbitrated after review and discussion of each case. Results: A total of 80 patients were included. The most common reason for sending the assay was unknown microbiologic diagnosis (78%), followed by avoiding invasive procedures (14%). The test had a positive impact in 34 (43%), a negative impact in 2 (3%), and uncertain or no impact in 44 (55%). A positive impact was observed in solid organ transplant recipients (SOTR, 71.4%, p = 0.003), sepsis (71.4%, p = 0.003), and those receiving antimicrobial agents for less than 7 days prior to mcfDNA testing (i.e., 61.8%, p = 0.004). Positive impact was driven primarily by de-escalation of antimicrobial therapy. Conclusion: Clinical impact of mcfDNA testing was highest in SOTR, patients with sepsis and patients who had been on antimicrobial therapy for less than 7 days. Positive impact was driven by de-escalation of antimicrobial therapy which may highlight a potential role for mcfDNA in the realm of stewardship.

20 September 2022 in Acta Orthopaedica
Verified
Journal Article
Open access
PDF file
JDJames Doub
James Doub
ASAkira Shishido
Akira Shishido
USUma Srikumaran
Uma Srikumaran
JHJohn Haskoor
John Haskoor
PTPhuong Tran-Nguyen
Phuong Tran-Nguyen
BCBenjamin K Chan
Benjamin K Chan

30 December 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TYTomohide Yamada
Tomohide Yamada
Daisuke YoneokaDaisuke Yoneoka
Daisuke Yoneoka
YHYuta Hiraike
Yuta Hiraike
KHKimihiro Hino
Kimihiro Hino
HTHiroyoshi Toyoshiba
Hiroyoshi Toyoshiba
TYToshimasa Yamauchi
Toshimasa Yamauchi
Background: Performing systematic reviews is a time-consuming and resource-intensive process. Objective: We investigated whether a machine learning system could perform systematic reviews more efficiently. Methods: All systematic reviews and meta-analyses of interventional randomized controlled trials cited in recent clinical guidelines from the American Diabetes Association, American College of Cardiology, American Heart Association (2 guidelines), and American Stroke Association were assessed. After reproducing the primary screening data set according to the published search strategy of each, we extracted correct articles (those actually reviewed) and incorrect articles (those not reviewed) from the data set. These 2 sets of articles were used to train a neural network–based artificial intelligence engine (Concept Encoder, Fronteo Inc). The primary endpoint was work saved over sampling at 95% recall (WSS@95%). Results: Among 145 candidate reviews of randomized controlled trials, 8 reviews fulfilled the inclusion criteria. For these 8 reviews, the machine learning system significantly reduced the literature screening workload by at least 6-fold versus that of manual screening based on WSS@95%. When machine learning was initiated using 2 correct articles that were randomly selected by a researcher, a 10-fold reduction in workload was achieved versus that of manual screening based on the WSS@95% value, with high sensitivity for eligible studies. The area under the receiver operating characteristic curve increased dramatically every time the algorithm learned a correct article. Conclusions: Concept Encoder achieved a 10-fold reduction of the screening workload for systematic review after learning from 2 randomly selected studies on the target topic. However, few meta-analyses of randomized controlled trials were included. Concept Encoder could facilitate the acquisition of evidence for clinical guidelines.

1 December 2022 in Current Treatment Options in Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ABAshley H. Barnes
Ashley H. Barnes
CSChristopher Smith
Christopher Smith
ADAditee Dash
Aditee Dash
ASAkira A. Shishido
Akira A. Shishido

2 March 2021 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
ASAkira A. Shishido
Akira A. Shishido
AVAlexander Vostal
Alexander Vostal
RMRomana Mayer
Romana Mayer
CHCheng‐Ying Ho
Cheng‐Ying Ho
JBJohn W Baddley
John W Baddley

21 July 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
ASAkira A Shishido
Akira A Shishido
GWGary P Wormser
Gary P Wormser
Alpha-gal syndrome (AGS) is an emerging allergic disease caused by an immunoglobulin E (IgE) response to galactose-α-1,3-galactose (alpha-gal), a sugar found in mammalian meat. The initial IgE sensitization follows a bite from the Amblyomma americanum (lone star) tick in the United States, although other tick species can also cause the disease. AGS presents with delayed symptoms, primarily gastrointestinal or allergic reactions like urticaria or anaphylaxis, hours after mammalian meat consumption. The nonspecificity of the symptoms can delay the diagnosis of AGS for years. Diagnosis relies on clinical evaluation and detection of alpha-gal–specific IgE in blood. As the lone star tick's range is expanding beyond the southern United States, AGS is gaining recognition in other regions. However, many healthcare providers remain unaware of the condition, leading to misdiagnosis. Infectious diseases physicians who frequently evaluate patients with tick exposure must be familiar with AGS, including tick identification, bite prevention, and knowledge of the alpha-gal–containing vaccines.